Completed PHASE4 INTERVENTIONAL 4-arm NCT02592408

A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan (MalTreSu)

A Study to Assess Current Standard Malaria Treatment Guidelines and Evaluate Recently Developed G6PD Diagnostic Tools in the Republic of the Sudan

Sponsor: Menzies School of Health Research

Conditions Malaria

Interventions 14DPQ 14DPQ on Day 42 ASP SDPQ

Updated 6 times since 2017 Last updated: Jan 31, 2017 Started: Nov 30, 2015 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Malaria and is currently completed. Menzies School of Health Research leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Menzies School of Health Research
University of Khartoum

Data source: Menzies School of Health Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Khartoum, Sudan
• New Halfa, Sudan